BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16751365)

  • 1. Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU).
    Jha P; Sohn JH; Xu Q; Wang Y; Kaplan HJ; Bora PS; Bora NS
    J Immunol; 2006 Jun; 176(12):7221-31. PubMed ID: 16751365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.
    Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3492-502. PubMed ID: 11006244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of complement activation by recombinant Crry inhibits experimental autoimmune anterior uveitis (EAAU).
    Manickam B; Jha P; Hepburn NJ; Morgan BP; Harris CL; Bora PS; Bora NS
    Mol Immunol; 2010; 48(1-3):231-9. PubMed ID: 20843553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD59 protects rat kidney from complement mediated injury in collaboration with crry.
    Watanabe M; Morita Y; Mizuno M; Nishikawa K; Yuzawa Y; Hotta N; Morgan BP; Okada N; Okada H; Matsuo S
    Kidney Int; 2000 Oct; 58(4):1569-79. PubMed ID: 11012891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tumor-expressed inhibitor of the early but not late complement lytic pathway enhances tumor growth in a rat model of human breast cancer.
    Caragine TA; Okada N; Frey AB; Tomlinson S
    Cancer Res; 2002 Feb; 62(4):1110-5. PubMed ID: 11861390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific collaboration between rat membrane complement regulators Crry and CD59 protects peritoneum from damage by autologous complement activation.
    Mizuno T; Mizuno M; Morgan BP; Noda Y; Yamada K; Okada N; Yuzawa Y; Matsuo S; Ito Y
    Nephrol Dial Transplant; 2011 Jun; 26(6):1821-30. PubMed ID: 21098015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and functional analysis of rat CD59 and chimeric CD59-Crry as active soluble proteins in Pichia pastoris.
    Quigg RJ; He C; Hack BK; Alexander JJ; Morgan BP
    Immunology; 2000 Jan; 99(1):46-53. PubMed ID: 10651940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
    Miwa T; Zhou L; Hilliard B; Molina H; Song WC
    Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crry, a complement regulatory protein, modulates renal interstitial disease induced by proteinuria.
    Hori Y; Yamada K; Hanafusa N; Okuda T; Okada N; Miyata T; Couser WG; Kurokawa K; Fujita T; Nangaku M
    Kidney Int; 1999 Dec; 56(6):2096-106. PubMed ID: 10594785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular complement regulation is overwhelmed in passive Heymann nephritis.
    Cunningham PN; Hack BK; Ren G; Minto AW; Morgan BP; Quigg RJ
    Kidney Int; 2001 Sep; 60(3):900-9. PubMed ID: 11532085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local inflammation caused by a monoclonal antibody that blocks the function of the rat membrane inhibitor of C3 convertase.
    Nishikawa K; Matsuo S; Okada N; Morgan BP; Okada H
    J Immunol; 1996 Feb; 156(3):1182-8. PubMed ID: 8557996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel bifunctional chimeric complement inhibitor that regulates C3 convertase and formation of the membrane attack complex.
    Fodor WL; Rollins SA; Guilmette ER; Setter E; Squinto SP
    J Immunol; 1995 Nov; 155(9):4135-8. PubMed ID: 7594566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of complement alternative pathway suppresses experimental autoimmune anterior uveitis by modulating T cell responses.
    Manickam B; Jha P; Matta B; Liu J; Bora PS; Bora NS
    J Biol Chem; 2011 Mar; 286(10):8472-8480. PubMed ID: 21216963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of complement regulatory membrane proteins in ischaemia-reperfusion injury of rat gastric mucosa.
    Iwata F; Joh T; Tada T; Okada N; Morgan BP; Yokoyama Y; Itoh M
    J Gastroenterol Hepatol; 1999 Oct; 14(10):967-72. PubMed ID: 10530491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of mutations in rat CD59 that increase the complement regulatory activity.
    Hinchliffe SJ; Morgan BP
    Biochemistry; 2000 May; 39(19):5831-7. PubMed ID: 10801333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical studies on melanin associated antigen (MAA) induced experimental autoimmune anterior uveitis (EAAU).
    Kim MC; Kabeer NH; Tandhasetti MT; Kaplan HJ; Bora NS
    Curr Eye Res; 1995 Aug; 14(8):703-10. PubMed ID: 8529406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of adenovirus vectors encoding rat complement regulators for use in therapy in rodent models of inflammatory diseases.
    McGrath Y; Wilkinson GW; Spiller OB; Morgan BP
    J Immunol; 1999 Dec; 163(12):6834-40. PubMed ID: 10586084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in glomerular mesangial and endothelial cells.
    Quigg RJ; Morgan BP; Holers VM; Adler S; Sneed AE; Lo CF
    Kidney Int; 1995 Aug; 48(2):412-21. PubMed ID: 7564108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of complement components and reduced regulator expression in alcohol-induced liver injury in the rat.
    Järveläinen HA; Väkevä A; Lindros KO; Meri S
    Clin Immunol; 2002 Oct; 105(1):57-63. PubMed ID: 12483994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complement system plays a critical role in the development of experimental autoimmune anterior uveitis.
    Jha P; Sohn JH; Xu Q; Nishihori H; Wang Y; Nishihori S; Manickam B; Kaplan HJ; Bora PS; Bora NS
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1030-8. PubMed ID: 16505038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.